Literature DB >> 871369

Evidence for a common tumour-associated antigen in extracts of human bronchogenic carcinoma.

B Kelly, J G Levy.   

Abstract

Xeno-antiserum specific for antigenic components of bronchogenic carcinoma was raised in rabbits, by passively immunizing them to normal human lung antigens at the same time as immunization with a tumour extract from a squamous-cell carcinoma. Antiserum so raised contained minimal quantities of anti-normal antibody which could be removed by a single absorption with glutaral-dehyde-insolubilized normal lung extract. When tested by quantitative complement fixation with a panel of tumour extracts from surgical specimens, it was found that the antiserum gave positive complement fixation with all squamous-cell carcinoma extracts tested, and with some of the extracts from bronchogenic carcinomas of differing pathological types. The antiserum was essentially negative for pooled extracts from normal lung, liver and spleen but gave a weak positive reaction with an extract of pooled foetal lung tissue.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 871369      PMCID: PMC2025541          DOI: 10.1038/bjc.1977.125

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  5 in total

1.  A comparison of the von Krogh formula (logistic function) and the method of probits as applied to hemolysis by complement.

Authors:  B H WAKSMAN
Journal:  J Immunol       Date:  1949-12       Impact factor: 5.422

2.  Immunochemical studies on human lung cancer antigens soluble in 50 per cent saturated ammonium sulfate.

Authors:  A Yachi; Y Matsuura; C M Carpenter; L Hyde
Journal:  J Natl Cancer Inst       Date:  1968-04       Impact factor: 13.506

3.  The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents.

Authors:  S Avrameas; T Ternynck
Journal:  Immunochemistry       Date:  1969-01

4.  Studies on the antigenic properties of egg-white lysozyme. I. Isolation and characterization of a tryptic peptide from reduced and alkylated lysozyme exhibiting haptenic activity.

Authors:  J Gerwing; K Thompson
Journal:  Biochemistry       Date:  1968-11       Impact factor: 3.162

5.  The detection by immunodiffusion of tumour associated antigenic components in extracts of human bronchongenic carcinoma.

Authors:  R D Watson; A G Smith; J G Levy
Journal:  Br J Cancer       Date:  1975-09       Impact factor: 7.640

  5 in total
  5 in total

1.  Tumour-associated antigens in lung cancer: the possibility for a serologic assay.

Authors:  B S Kelly; J G Levy
Journal:  Can Med Assoc J       Date:  1980-05-10       Impact factor: 8.262

2.  Specific and nonspecific immunotherapy as an adjunct to curative surgery for cancer of the lung.

Authors:  A C Hollinshead; T H Stewart
Journal:  Yale J Biol Med       Date:  1981 Sep-Oct

3.  Detection of tumour-associated antigens in human bronchogenic carcinoma by the enzyme-linked immunosorbent assay (ELISA).

Authors:  B S Kelly; J G Levy
Journal:  Br J Cancer       Date:  1980-03       Impact factor: 7.640

4.  Purification of a protein associated with human bronchogenic squamous-cell carcinoma.

Authors:  B S Kelly; J G Levy
Journal:  Br J Cancer       Date:  1979-03       Impact factor: 7.640

5.  A tumour-associated antigen from the pleural effusion of patients with squamous-cell carcinoma of lung.

Authors:  A Wolf
Journal:  Br J Cancer       Date:  1978-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.